ストックスクリーナーアプリを入手
20.47
0.10%
-0.02
前日終値:
$20.49
開ける：
$20.55
24時間の取引高:
57,205
Relative Volume:
0.05
時価総額：
$1.92B
収益：
$193.35M
当期純損益:
$-177.58M
株価収益率:
-8.3551
EPS:
-2.45
ネットキャッシュフロー:
$-172.43M
1週間 パフォーマンス:
+0.05%
1か月 パフォーマンス:
-4.79%
6か月 パフォーマンス:
+3.54%
1年 パフォーマンス:
+5.25%
1日の値動き範囲:
$20.31
$20.65
1週間の範囲:
$19.74
$20.88
52週間の値動き範囲:
$16.60
$28.47
Schrodinger Inc Stock (SDGR) Company Profile
SDGR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
20.48 | 1.92B | 193.35M | -177.58M | -172.43M | -2.45 |
|
VEEV
Veeva Systems Inc
|
281.31 | 46.43B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
68.01 | 12.01B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
60.60 | 10.79B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
105.63 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
39.89 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-02 | 開始されました | Leerink Partners | Outperform |
| 2023-12-05 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 再開されました | Piper Sandler | Overweight |
| 2022-12-19 | 開始されました | Goldman | Neutral |
| 2022-03-01 | 開始されました | Citigroup | Buy |
| 2021-11-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 開始されました | Piper Sandler | Overweight |
| 2021-11-11 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-10-13 | 開始されました | Berenberg | Buy |
| 2021-09-01 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 開始されました | Craig Hallum | Buy |
| 2020-11-23 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-10-12 | アップグレード | Jefferies | Hold → Buy |
| 2020-03-02 | 開始されました | BMO Capital Markets | Outperform |
| 2020-03-02 | 開始されました | Jefferies | Hold |
| 2020-03-02 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Schrodinger Inc (SDGR) 最新ニュース
Schrodinger Announces Board Elections and Approvals - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger - Bluefield Daily Telegraph
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Where are the Opportunities in (SDGR) - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, ... - Eagle-Tribune
Harbor Capital Advisors Inc. Grows Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger slides after early-stage trial data for cancer therapy - MSN
Schrödinger: Assessing The Signal And The Noise In The Phase 1 Results - Seeking Alpha
Schrödinger (SDGR) Shares Dip After Initial Phase 1 Trial Data - GuruFocus
Schrödinger Reports Encouraging Initial Phase 1 Clinical Data fo - GuruFocus
Schrodinger Reports 22% Response Rate in Phase 1 Trial of SGR-1505 for B-Cell Cancers; Shares Fall - MarketScreener
Schrödinger stock slides on cancer trial data (SDGR:NASDAQ) - Seeking Alpha
Transcript : Schrödinger, Inc.Special Call - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc.SDGR - WV News
Schrodinger (SDGR) Reports Promising Phase 1 Results of SGR-1505 | SDGR Stock News - GuruFocus
Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress - Eagle-Tribune
Day 9 of Gains Streak for Schrodinger Stock with 24% Return (vs. 38% YTD) [6/11/2025] - Trefis
Schrodinger Inc (SDGR) Trading 5.17% Higher on Jun 11 - GuruFocus
California State Teachers Retirement System Reduces Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrödinger, Inc. (NASDAQ:SDGR) Receives Average Recommendation of “Buy” from Analysts - Defense World
Comparing Schrödinger (NASDAQ:SDGR) & Salarius Pharmaceuticals (NASDAQ:SLRX) - Defense World
Schrodinger Inc (SDGR) Trading 4.34% Higher on Jun 6 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Schrodinger Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily
Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Shareholders to Connect - ACCESS Newswire
Kalkine NASDAQ 100 Top Stocks Leading Technology Giants Driving Market Growth - Kalkine Media
24,500 Shares in Schrödinger, Inc. (NASDAQ:SDGR) Acquired by Two Sigma Advisers LP - Defense World
Bank of America Corp DE Reduces Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrodinger at Jefferies Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Schrodinger at Jefferies Conference: Strategic Growth and Challenges - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Schrödinger, Inc. (SDGR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Two Sigma Investments LP Acquires New Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Schrödinger, Inc. (SDGR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Top 5 AI & Digital Biotech Companies (June 2025) - Securities.io
Schrödinger, Inc. (SDGR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
ProShare Advisors LLC Has $323,000 Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Layoff Tracker: iTeos Winds Down Operations - BioSpace
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer - 01net
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer | SDGR Stock News - GuruFocus
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) To Newly Appointed Chief Commercial Officer - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Schrödinger, Inc. (SDGR) And Encourages Investors to Connect - ACCESS Newswire
Schrodinger appoints Mannix Aklian as chief commercial officer - TipRanks
Schrödinger Appoints Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing - citybiz
Schrödinger Expands Executive Leadership Team with Appointment o - GuruFocus
Schrödinger Expands Executive Leadership Team With Appointment Of Mannix Aklian As Chief Commercial Officer - MarketScreener
Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing | SDGR Stock News - GuruFocus
Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing - Yahoo Finance
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $610,000 Stock Holdings in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World
Schrodinger Inc (SDGR) 財務データ
収益
当期純利益
現金流量
EPS
Schrodinger Inc (SDGR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Akinsanya Karen | President of R&D, Therapeutics |
Apr 14 '25 |
Sale |
25.09 |
16,723 |
419,570 |
15,625 |
1.01%
0.77%
大文字化:
|
ボリューム (24 時間):